SPARCPharmaceuticals
Sun Pharma Advanced Research Company Ltd — Balance Sheet
₹114.89
-8.03%
Sun Pharma Advanced Research Company Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 32.45 Cr | 32.45 Cr | 32.45 Cr | 27.19 Cr | — |
| Share Issued | 32.45 Cr | 32.45 Cr | 32.45 Cr | 27.19 Cr | — |
| Net Debt | 256.22 Cr | 41.67 Cr | — | 73.78 Cr | 221.24 Cr |
| Total Debt | 265.13 Cr | 57.66 Cr | 15.68 Cr | 79.21 Cr | — |
| Tangible Book Value | -270.60 Cr | 83.04 Cr | 487.31 Cr | 8.11 Cr | — |
| Invested Capital | 41.24 Cr | 172.76 Cr | 512.83 Cr | 106.23 Cr | — |
| Working Capital | -348.04 Cr | 4.33 Cr | 276.02 Cr | -100.28 Cr | — |
| Net Tangible Assets | -270.60 Cr | 83.04 Cr | 487.31 Cr | 8.11 Cr | — |
| Capital Lease Obligations | 6.95 Cr | 10.66 Cr | 15.62 Cr | 4.21 Cr | — |
| Common Stock Equity | -216.95 Cr | 125.76 Cr | 512.78 Cr | 31.23 Cr | — |
| Total Capitalization | -116.95 Cr | 125.76 Cr | 512.78 Cr | 31.23 Cr | — |
| Total Equity Gross Minority Interest | -216.95 Cr | 125.76 Cr | 512.78 Cr | 31.23 Cr | — |
| Stockholders Equity | -216.95 Cr | 125.76 Cr | 512.78 Cr | 31.23 Cr | — |
| Other Equity Interest | -249.40 Cr | 93.30 Cr | 480.32 Cr | 234.26 Cr | — |
| Retained Earnings | -2.32K Cr | -1.98K Cr | -1.59K Cr | -1.37K Cr | — |
| Additional Paid In Capital | 2.04K Cr | 2.04K Cr | 2.04K Cr | 1.11K Cr | — |
| Capital Stock | 32.45 Cr | 32.45 Cr | 32.45 Cr | 27.19 Cr | — |
| Common Stock | 32.45 Cr | 32.45 Cr | 32.45 Cr | 27.19 Cr | — |
| Total Liabilities Net Minority Interest | 552.48 Cr | 389.29 Cr | 317.35 Cr | 248.86 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 178.24 Cr | 124.23 Cr | 138.41 Cr | 77.43 Cr | — |
| Other Non Current Liabilities | 62.60 Cr | 103.49 Cr | 117.65 Cr | 66.84 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 7.68 Cr | 6.05 Cr | 8.14 Cr | 8.15 Cr | — |
| Tradeand Other Payables Non Current | 0.11 Cr | 3.19 Cr | — | — | — |
| Non Current Deferred Revenue | 62.60 Cr | 103.49 Cr | 117.65 Cr | 66.84 Cr | — |
| Long Term Debt And Capital Lease Obligation | 106.95 Cr | 10.66 Cr | 12.62 Cr | 2.44 Cr | — |
| Long Term Capital Lease Obligation | 6.95 Cr | 10.66 Cr | 12.62 Cr | 2.44 Cr | — |
| Long Term Debt | 100.00 Cr | 0.00 | — | 0.00 | 112.50 Cr |
| Long Term Provisions | 7.68 Cr | 6.05 Cr | 8.14 Cr | 8.15 Cr | — |
| Current Liabilities | 374.24 Cr | 265.06 Cr | 178.95 Cr | 171.43 Cr | — |
| Other Current Liabilities | 11.65 Cr | 15.06 Cr | 9.41 Cr | 5.76 Cr | — |
| Current Deferred Taxes Liabilities | 0.44 Cr | 1.65 Cr | 0.00 | — | — |
| Current Debt And Capital Lease Obligation | 158.19 Cr | 47.00 Cr | 3.06 Cr | 76.78 Cr | — |
| Current Capital Lease Obligation | 3.79 Cr | 3.49 Cr | 3.00 Cr | 1.78 Cr | — |
| Current Debt | 158.19 Cr | 47.00 Cr | 0.05 Cr | 75.00 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 7.45 Cr | 12.24 Cr | 6.49 Cr | 5.28 Cr | — |
| Current Provisions | 7.45 Cr | 12.24 Cr | 6.49 Cr | 5.28 Cr | — |
| Payables | 138.17 Cr | 172.35 Cr | 159.95 Cr | 83.39 Cr | — |
| Other Payable | 20.44 Cr | 26.57 Cr | 11.70 Cr | 11.21 Cr | — |
| Total Tax Payable | 0.44 Cr | 1.65 Cr | — | — | — |
| Accounts Payable | 117.72 Cr | 145.78 Cr | 148.25 Cr | 72.19 Cr | — |
| Total Assets | 335.53 Cr | 515.04 Cr | 830.13 Cr | 280.08 Cr | — |
| Total Non Current Assets | 309.34 Cr | 245.66 Cr | 375.16 Cr | 208.93 Cr | — |
| Other Non Current Assets | 71.85 Cr | 0.80 Cr | 2.41 Cr | 0.60 Cr | — |
| Non Current Prepaid Assets | 72.31 Cr | 0.85 Cr | 1.12 Cr | 0.58 Cr | — |
| Non Current Deferred Taxes Assets | 2.31 Cr | 1.26 Cr | 0.00 | 0.00 | — |
| Investmentin Financial Assets | 26.11 Cr | 25.49 Cr | 150.00 Cr | 0.00 | — |
| Available For Sale Securities | 26.11 Cr | 25.49 Cr | 150.00 Cr | 23.18 Cr | — |
| Goodwill And Other Intangible Assets | 53.65 Cr | 42.71 Cr | 25.47 Cr | 23.12 Cr | — |
| Other Intangible Assets | 53.65 Cr | 42.71 Cr | 25.47 Cr | 23.12 Cr | — |
| Net PPE | 99.26 Cr | 109.04 Cr | 109.03 Cr | 95.58 Cr | — |
| Accumulated Depreciation | -58.23 Cr | -48.60 Cr | -39.66 Cr | -40.68 Cr | — |
| Gross PPE | 157.48 Cr | 157.64 Cr | 148.69 Cr | 136.26 Cr | — |
| Construction In Progress | 0.56 Cr | 1.69 Cr | 3.62 Cr | 4.19 Cr | — |
| Other Properties | 17.80 Cr | 17.67 Cr | 17.88 Cr | 8.55 Cr | — |
| Machinery Furniture Equipment | 100.04 Cr | 99.39 Cr | 88.79 Cr | 85.48 Cr | — |
| Buildings And Improvements | 31.04 Cr | 30.86 Cr | 30.36 Cr | 30.01 Cr | — |
| Land And Improvements | 8.04 Cr | 8.04 Cr | 8.04 Cr | 8.04 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 26.20 Cr | 269.39 Cr | 454.96 Cr | 71.15 Cr | — |
| Other Current Assets | 5.65 Cr | 53.71 Cr | 15.07 Cr | 27.34 Cr | — |
| Prepaid Assets | 5.65 Cr | 53.71 Cr | 12.89 Cr | 27.34 Cr | — |
| Other Receivables | 0.76 Cr | 40.52 Cr | 4.70 Cr | 3.19 Cr | — |
| Taxes Receivable | 1.76 Cr | 2.50 Cr | 2.18 Cr | — | — |
| Accounts Receivable | 16.06 Cr | 15.53 Cr | 32.71 Cr | 27.74 Cr | — |
| Allowance For Doubtful Accounts Receivable | -2.05 Cr | -2.05 Cr | 0.00 | 0.00 | — |
| Gross Accounts Receivable | 18.11 Cr | 17.58 Cr | 32.71 Cr | 27.74 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 1.96 Cr | 157.13 Cr | 402.47 Cr | 12.89 Cr | — |
| Other Short Term Investments | 2.36 Cr | 151.80 Cr | 401.89 Cr | 11.66 Cr | — |
| Cash And Cash Equivalents | 1.96 Cr | 5.33 Cr | 0.58 Cr | 1.22 Cr | — |
| Cash Financial | 1.96 Cr | 5.33 Cr | 0.58 Cr | 1.22 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Restricted Cash | — | 0.00 | 21000.00 | 21000.00 | 71000.00 |
| Cash Equivalents | — | — | 110.99 Cr | 0.00 | — |
| Assets Held For Sale Current | — | — | — | 0.00 | 3.31 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sun Pharma Advanced Research Company Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.